This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Wed, 04/16/2025 - 14:19 April 16, 2025 An artificial intelligence (AI) program trained to review images from a common medical test can detect early signs of tricuspid heartvalve disease and may help doctors diagnose and treat patients sooner, according to research from the Smidt Heart Institute at Cedars-Sinai.
Recently published research shows a medical device may be beneficial for patients who have previously had a stroke and are planning to undergo a transcatheter aortic valve replacement, a type of heartvalve operation.
When a patient needs a new heartvalve, the current mechanical and tissue replacements each have strengths and weaknesses. Now, a team of researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing -- and life-saving -- for many.
Human skin cells have been reprogrammed into heartvalve cells and then used to successfully transplant a pig heartvalve into a rodent, led by the research of a Northeastern University professor.
Patients aged between 50 to 70 years with a mechanical heartvalve replacement had better long-term survival compared to those with a biological valve, new research has found.
The sheer scale of undiagnosed heartvalve disease in our aging population has been revealed for the first time, thanks to new research led by the University of East Anglia.
tim.hodson Mon, 03/17/2025 - 14:56 March 17, 2025 Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Associations flagship journal Circulation. are forms of congenital heart defects (CHD). In the U.S.,
When a patient needs a new heartvalve, the current mechanical and tissue replacements each have strengths and weaknesses. Now, a team of UBC Okanagan researchers believe they have found a way to harness the strengths of both technologies in a way that could be life-changing—and life-saving—for many.
Recent research has significantly advanced our understanding of RHD, shedding light on the immune-to-autoimmune transition, neoangiogenesis, and lymphangiogenesis processes. Addressing these issues will require a global health collaboration involving healthcare professionals, policymakers, and advocacy groups.
Findings from a published case series research letter by the Henry Ford Health Structural Heart Disease team show that severe mitral stenosis, due to a build-up of calcium deposits in the mitral valve common in elderly patients, can be safely and successfully treated using Intravascular lithotripsy (IVL)-enabled percutaneous balloon mitral valvuloplasty. (..)
These key takeaways from the research letter on IVL-facilitated valvuloplasty for severely calcified mitral valve stenosis are published in the Journal of the American College of Cardiology (JACC) Cardiovascular Interventions. The research letter’s lead author, Gennaro Giustino, M.D.,
Future research should focus on longitudinal studies, collaboration across institutions, and exploration of implementation strategies. The importance of involving diverse healthcare professionals in ERAS development and implementation to enhance team spirit, motivation, and overall success is highlighted by our findings.
A team of researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) in Madrid has identified the molecular mechanisms that control the activity of genes involved in both the correct formation of the heartvalves and the prevention of their subsequent calcification.
Combining a biological heart and a silicone robotic pump, researchers created a biorobotic heart that beats like a real one, with a focus on a valve on the left side of the heart.
Research Highlights: Edoxaban, a medication taken orally to prevent blood clots from forming, was found to be as effective and safe for stroke and blood clot prevention in patients after heartvalve replacement surgery as warfarin, the current.
(MedPage Today) -- Undiagnosed heartvalve disease was highly prevalent in a large community study of otherwise healthy people recruited from primary care in the U.K., researchers found. There was a 28.2% prevalence of mild, moderate, or severe.
Dr. Shettys team followed 252 patients who underwent the Ross procedure, a heartvalve replacement operation commonly used to treat younger patients with severe aortic valve disease. at 5,10,15 and 20 years respectively, the researchers reported. Shettys team found that survival rates were 95.8% at 5 years, 94.3%
Replacement heartvalves that grow inside the body are a step closer to reality following studies led by researchers at Imperial. The results are published in Communications Biology.
IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heartvalves (SEV). Forty-seven received SEVs using COL, and 50 with CON techniques.
Combining a biological heart and a silicone robotic pump, researchers created a biorobotic heart that beats like a real one, focusing on a valve on the left side of the heart.
In such scenarios, cardiologists’ primary form of treatment for children with coronary heart disease is a heartvalve implant. Unfortunately, the traditional pulmonary valves have a fixed diameter that can’t match the size of the child’s heart over time.
This qualitative study explores the perceived benefits and intervention-specific needs of patients who received expectation-focused intervention in the context of heartvalve surgery. In addition, it explores potential barriers and adverse effects.
Although well-known for their thromboresistance, bileaflet mechanical heartvalves (BMHV) require lifelong anti-thrombotic therapy. This must be associated with a certain level of thrombogenicity. Since both t.
BACKGROUND:A main obstacle in current valvular heart disease research is the lack of high-quality homogeneous functional heartvalve cells. Human induced pluripotent stem cells (hiPSCs)-derived heartvalve cells may help with this dilemma.
Patients aged between 50 to 70years with a mechanical heartvalve replacement had better long-term survival compared to those with a biological valve, new research led by the University of Bristol has found. The study is published in the European Journal of Cardio-Thoracic Surgery.
This study aims to compare the efficacy of the Age-adjusted Charlson Comorbidity Index (ACCI) and the Elixhauser-Van Walraven Comorbidity Index (ECI-VW) in predicting mortality risk among patients undergoing h.
Background Valvular heart disease is a major health concern worldwide. The effective management of patients undergoing valve replacement determines their prognosis. Bibliometric analysis of studies on managing patients with artificial heartvalves has not been previously performed.
However, with the compelling evidence on the safety and efficacy of transcatheter aortic valve replacement (TAVR), it has become the gold standard treatment option for many patients with symptomatic severe AS. Transfemoral access has been the preferred method for transcatheter heartvalve delivery.
Stroke is a potentially debilitating complication of heartvalve replacement surgery, with rates ranging from 1 to 10%. Despite advancements in surgical techniques, the incidence of postoperative stroke remain.
Ismail El-Hamamsy, MD, PhD, Named President of the HeartValve Society 2. Allina Health Minneapolis Heart Institute is First in Minnesota to Implant Barostim Therapy to Improve Symptoms of Heart Failure 7. Machine Learning Informs a New Tool to Guide Treatment for Acute Decompensated Heart Failure 8.
Doctors at Mayo Clinic have used a new catheter-based approach to draw out resistant pockets of infection that settle in the heart, known as right-sided infective endocarditis, without surgery. Unless treated quickly, the walled-off infections can grow, severely damaging heartvalves and potentially affecting other organs as well.
Research Highlights: Artificial intelligence (AI) and deep learning models may help to predict the risk of cardiovascular disease events and detect heart valvular disease, according to two preliminary research studies. One study found that artificial.
In tricuspid valve regurgitation, a complex condition that Cedars-Sinai experts regularly treat, the valve between two heart chambers on the right side doesn't open or close properly. How has treatment for tricuspid valve disease evolved? Image by Getty. tim.hodson Tue, 02/18/2025 - 10:08 Feb.
In the heart of Adana, the Adana City Health Training and Research Center recently became the epicenter of groundbreaking advancements in medical education. Last week marked a significant milestone as the center of excellence for Transcatheter Aortic Valve Implantation (TAVI) procedures hosted a highly successful TAVI Masterclass.
The Center will also focus on clinical trials for transcatheter edge-to-edge repair (TEER) devices for tricuspid regurgitation, new devices for transcatheter mitral valve replacement, and advancing the field of robotic valve surgery. “At
ConclusionsWe developed a preoperative risk prediction model for AKI after heartvalve replacement in patients with normal renal function, which demonstrated satisfactory discrimination and calibration.
Photo by Cedars-Sinai milla1cf Mon, 06/24/2024 - 20:17 June 24, 2024 — Aakriti Gupta, MD , and Michelle Kittleson, MD, PhD , cardiologists in the Smidt Heart Institute at Cedars-Sinai , have been selected to join the senior editorial team of the Journal of the American College of Cardiology (JACC), effective July 1.
The aim of this study was to identify the risk factors for postoperative delirium (POD) in elderly patients undergoing heartvalve surgery with cardiopulmonary bypass (CPB).
The first cases were performed by Dr. Tamim Nazif , Director of Clinical Research, Dr. Susheel Kodali , Professor of Medicine and Director of the Structural Heart and Valve Center , and Dr. Isaac George , Surgical Director of the HeartValve Center.
Severe disease is managed with valve replacement procedures, which entail high health care–related costs and postprocedural morbidity and mortality. Robust ongoing research programs have elucidated many important molecular pathways contributing to primary valvular heart disease.
His impressive international academic collaborations include the establishment of multiple global registries and the training of heart teams in structural heart imaging and procedures worldwide.
Image courtesy of Henry Ford Health milla1cf Wed, 02/21/2024 - 19:07 February 21, 2024 — An 80-year-old woman from Frankenmuth, Michigan is the first Henry Ford Health structural heart disease patient—and the first ever in Michigan—to receive a new transcatheter heartvalve device for treating severe tricuspid regurgitation.
Cardiogenic dementia is a cognitive impairment caused by heart dysfunction and has received increasing research attention. This study describes the changes in cognitive function associated with coronary artery disease, myocardial infarction, heart failure, atrial fibrillation and heartvalve disease.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content